Title |
Psychiatric comorbidities in patients with major depressive disorder
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, November 2014
|
DOI | 10.2147/ndt.s72026 |
Pubmed ID | |
Authors |
Papan Thaipisuttikul, Pichai Ittasakul, Punjaporn Waleeprakhon, Pattarabhorn Wisajun, Sudawan Jullagate |
Abstract |
Psychiatric comorbidities are common in major depressive disorder (MDD). They may worsen outcome and cause economic burden. The primary objective was to examine the prevalence of psychiatric comorbidities in MDD. The secondary objectives were to compare the presence of comorbidities between currently active and past MDD, and between patients with and without suicidal risk. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Chile | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 237 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Denmark | 1 | <1% |
Unknown | 235 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 38 | 16% |
Student > Master | 29 | 12% |
Researcher | 25 | 11% |
Student > Ph. D. Student | 20 | 8% |
Student > Doctoral Student | 19 | 8% |
Other | 26 | 11% |
Unknown | 80 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 58 | 24% |
Medicine and Dentistry | 30 | 13% |
Neuroscience | 17 | 7% |
Biochemistry, Genetics and Molecular Biology | 8 | 3% |
Nursing and Health Professions | 7 | 3% |
Other | 31 | 13% |
Unknown | 86 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2019.
All research outputs
#4,685,347
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#634
of 3,132 outputs
Outputs of similar age
#50,769
of 273,823 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#9
of 49 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.